Conference Coverage
Conference Coverage
Flu vaccines cut seasonal death in heart failure patients
Conference Coverage
Anticoagulation not routinely needed after TAVR: ADAPT-TAVR
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual-antiplatelet therapy, but no reduction in...
Conference Coverage
Early PCSK9 inhibition in AMI yields plaque regression
‘Go early and go low’ is an expert’s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received...
Conference Coverage
APOLLO: SLN360 clears first major hurdle, hammering Lp(a)
The results add to growing enthusiasm for achieving the ‘holy grail’ of a lipoprotein(a)-specific lowering agent, but whether it will reduce...
Conference Coverage
New HF guidelines feature ‘quad’ therapy, tweaked terminology
They include new generalist-friendly labels for the traditional but obscurely named four stages of HF that, it is hoped, will have wider reach and...
Conference Coverage
Supermarket diet advice improves DASH adherence: SuperWIN
People who received personalized nutrition education at the grocery store significantly improved adherence to a healthy diet, in a study where...
Conference Coverage
Mavacamten controlled hypertrophic cardiomyopathy for over 1 year
Conference Coverage
Novel cholesterol drug disappoints: TRANSLATE-TIMI 70
An investigational antisense oligonucleotide drug targeting a novel cholesterol pathway showed disappointing results in this phase 2b study.
Conference Coverage
Diltiazem fails to improve vasomotor dysfunction, angina in ANOCA: EDIT-CMD
In patients with angina and no coronary artery disease, 6 weeks of diltiazem did not improve most coronary function test results or angina...
Conference Coverage
VALOR-HCM: Novel drug may delay, avert invasive therapy in OHCM
Mavacamten looks promising as a medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic...
Conference Coverage
FAME 3 subanalysis adds twist to negative primary results
A quality of life subanalysis suggests PCI with fractional flow reserve might be preferred over CABG by at least some patients.